全球 POC 血糖测试市场规模、份额、成长分析（按配方、最终用途）- 产业预测，2023-2030 年

Global Point-of-care Glucose Testing Market Size, Share, Growth Analysis, By Prescription(OTC testing, and Prescription-based testing), By End-use(Hospitals, Diagnostic centers) - Industry Forecast 2023-2030

出版日期: 2023年11月17日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2021年全球POC血糖检测市场规模为31.7亿美元，预测期内（2023-2030年）复合年增长率为4.2%，从2022年的33亿美元增至2030年的45.9亿美元。预计将增长至10,000,000 美元。

由于糖尿病盛行率不断上升以及需要定期监测血糖以进行有效的疾病管理，医疗保健领域的全球 POC 血糖检测市场正在快速成长。该市场包括使用可提供即时结果的携带式血糖测试设备，使医疗保健专业人员和个人能够在治疗时方便地监测血糖值。 POC 血糖检测的优点包括快速得出结果、改善病患治疗结果并降低医疗成本。其主要目的是促进及时、准确的血糖监测，特别是对于糖尿病患者来说，使医疗保健专业人员能够就治疗计划和剂量调整做出资讯的决定，并且可以快速做出决定。此外，即时检测有助于早期发现、监测和干预，以改善糖尿病管理，透过提供即时资讯来管理个人健康，从而增强个人能力。全球糖尿病盛行率的不断上升以及人们对定期血糖监测重要性的认识不断增强，推动了该市场的发展。虽然有成长潜力，但测试设备的成本以及对精度和准确度的需求等问题是市场开拓的考虑因素。也就是说，POC 葡萄糖检测市场提供了重要的成长和创新机会。

POC 血糖检测全球细分市场分析

全球 POC 血糖检测市场按处方、最终用途和地区细分。按处方笺，市场分为非处方药检测和处方笺检测。依最终用途划分，市场分为医院、诊断中心、实验室、居家照护环境等。按地区划分，市场分为北美、欧洲、亚太地区、中东和非洲以及拉丁美洲。

全球POC血糖检测市场的驱动因素

全球 POC 血糖检测市场的关键驱动因素是全球糖尿病盛行率的不断上升。糖尿病盛行率的不断上升，加上定期和快速血糖监测的需求，正在推动对即时检测解决方案的需求。在护理点获取血糖测量的便利性和速度有助于更好的疾病管理和改善患者的治疗结果。

全球POC血糖检测市场的抑制因素

市场的一个潜在抑制因素是 POC 血糖检测设备的高成本。虽然这些设备提供便利和即时的效果，但初始投资和持续成本对于一些医疗保健提供者和患者来说可能是一个挑战。负担能力和报销问题可能会限制这些技术的普及，特别是在资源有限的地区。

全球POC血糖检测市场趋势

全球 POC 血糖检测市场的一个新兴趋势是数位健康技术和连接功能的整合。许多现代血糖测试设备都包含蓝牙和其他无线技术，可将资料无缝传输到智慧型手机和其他医疗保健平台。这种整合促进了患者和医疗保健提供者之间的远端监控、资料管理和即时通信，有助于更个人化和主动的糖尿病管理。

执行摘要
调查方法
母市场分析
主要市场考察
- 技术分析
- 价格分析
- 供应链分析
- 价值链分析
- 市场生态系统
- 智慧财产权分析
- 贸易分析
- Start-Ups分析
- 原料分析
- 创新矩阵
- 研发线产品分析
- 总体经济指标
- 主要投资分析
- 关键成功因素
- 竞争程度
市场动态及展望
- 市场动态
  - 促进因素
  - 机会
  - 抑制因素
  - 任务
- 监管形势
- 波特的分析
- 对未来中断的特殊考察
全球 POC 血糖检测市场：依处方分类
- 市场概况
- 场外测试
- 根据处方进行测试
全球 POC 血糖测试市场：依最终用途分类
- 市场概况
- 医院
- 诊断中心
- 研究
- 居家照护环境
- 其他的
全球POC血糖检测市场规模（按地区）
- 市场概况
- 北美洲
  - 美国
  - 加拿大
- 欧洲
  - 德国
  - 西班牙
  - 法国
  - 英国
  - 其他欧洲国家地区
- 亚太地区
  - 中国
  - 印度
  - 日本
  - 韩国
  - 其他亚太地区
- 拉丁美洲
  - 巴西
  - 其他拉丁美洲地区
- 中东和非洲 (MEA)
  - 海湾合作委员会国家
  - 南非
  - 其他中东/非洲地区
竞争形势
- 前5名企业对比
- 主要企业市场定位（2021年）
- 主要市场参与者所采取的策略
- 关键成功策略
- 近期市集活动
- 主要企业市场占有率（2021年）
主要企业简介
- Abbott（US）
- Dexcom（US）
- Roche（Switzerland）
- Ascensia Diabetes Care（Switzerland）
- LifeScan（US）
- Medtronic（US）
- Ypsomed（Switzerland）
- Animas（US）
- Insulet（US）
- Bayer（Germany）
- Nipro（Japan）
- Terumo（Japan）
- Arkray（Japan）
- Acon Laboratories（US）
- Freestyle（US）
- One Touch（US）
- Accu-Chek（Germany）
- Dario（US）
- iHealth（China）
- FreeStyle Libre（UK）

简介目录

Product Code: SQMIG15E2398

Global Point-of-care glucose testing Market size was valued at USD 3.17 Billion in 2021 and is poised to grow from USD 3.3 Billion in 2022 to USD 4.59 Billion by 2030, at a CAGR of 4.2% during the forecast period (2023-2030).

The global point-of-care glucose testing market is experiencing rapid growth within the healthcare sector, driven by the escalating prevalence of diabetes and the necessity for regular glucose monitoring for effective disease management. This market involves the utilization of portable glucose testing devices that offer immediate results, enabling both healthcare professionals and individuals to conveniently monitor blood glucose levels at the point of care. The advantages of point-of-care glucose testing include swift results, enhanced patient outcomes, and reduced healthcare costs. Its primary objective is to facilitate timely and accurate glucose monitoring, particularly for individuals managing diabetes, allowing healthcare professionals to make informed decisions regarding treatment plans and medication dosages adjustments promptly. Furthermore, point-of-care testing empowers individuals by providing real-time information to take control of their health, promoting early detection, monitoring, and intervention for improved diabetes management. The market is fueled by the increasing global incidence of diabetes, coupled with growing awareness about the importance of regular glucose monitoring. Despite its growth potential, challenges such as the cost of testing devices and the need for precision and accuracy pose considerations for the market's development. Nevertheless, the point-of-care glucose testing market presents significant opportunities for growth and innovation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Point-of-care glucose testing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Point-of-care glucose testing Market Segmental Analysis

The global point-of-care glucose testing market is segmented on the prescription, end-use, and region. By prescription, the market is segmented into OTC testing, Prescription-based testing. In terms of segmentation by end-use, the market is segmented into hospitals, diagnostic centers, research laboratories, home-care settings, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers in the Global Point-of-care glucose testing Market

A significant driver for the global point-of-care glucose testing market is the growing prevalence of diabetes worldwide. The increasing incidence of diabetes, coupled with the need for regular and rapid glucose monitoring, has driven the demand for point-of-care testing solutions. The convenience and speed of obtaining glucose readings at the point of care contribute to better disease management and improved patient outcomes.

Restraints in the Global Point-of-care glucose testing Market

A potential restraint for the market is the high cost associated with point-of-care glucose testing devices. While these devices offer convenience and immediate results, the initial investment and ongoing costs may pose a challenge for some healthcare providers and patients. Affordability and reimbursement issues can limit the widespread adoption of these technologies, especially in regions with resource constraints.

Market Trends of the Global Point-of-care glucose testing Market

An emerging trend in the global point-of-care glucose testing market is the integration of digital health technologies and connectivity features. Many modern glucose testing devices are equipped with Bluetooth or other wireless technologies, allowing seamless data transfer to smartphones or other healthcare platforms. This integration facilitates remote monitoring, data management, and real-time communication between patients and healthcare providers, contributing to more personalized and proactive diabetes management.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
  - Drivers
  - Opportunities
  - Restraints
  - Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
  - Drivers
  - Opportunities
  - Restraints
  - Challenges
- Regulatory Landscape
- Porters Analysis
  - Competitive rivalry
  - Threat of Substitute Products
  - Bargaining Power of Buyers
  - Threat of New Entrants
  - Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
  - Political Impact
  - Economic Impact
  - Social Impact
  - Technical Impact
  - Environmental Impact
  - Legal Impact
Global Point-of-care Glucose Testing Market by Prescription
- Market Overview
- OTC testing
- and Prescription-based testing
Global Point-of-care Glucose Testing Market by End-use
- Market Overview
- Hospitals
- Diagnostic centers
- Research laboratories
- Home-care settings
- and Others
Global Point-of-care Glucose Testing Market Size by Region
- Market Overview
- North America
  - USA
  - Canada
- Europe
  - Germany
  - Spain
  - France
  - UK
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - South Korea
  - Rest of Asia-Pacific
- Latin America
  - Brazil
  - Rest of Latin America
- Middle East & Africa (MEA)
  - GCC Countries
  - South Africa
  - Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
  - By Development
  - By Company
  - By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Abbott (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Dexcom (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Roche (Switzerland)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Ascensia Diabetes Care (Switzerland)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- LifeScan (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Medtronic (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Ypsomed (Switzerland)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Animas (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Insulet (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Bayer (Germany)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Nipro (Japan)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Terumo (Japan)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Arkray (Japan)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Acon Laboratories (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Freestyle (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- One Touch (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Accu-Chek (Germany)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Dario (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- iHealth (China)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- FreeStyle Libre (UK)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments